Table 1.
Participants’ Characteristics at Baseline
| All (N = 127) | AF-CBT (n = 65) | Control (n = 62) | |
|---|---|---|---|
| Age (y) | 65.4 ± 8.3 | 65.1 ± 8.4 | 65.7 ± 7.5 |
| Females | 74 (58) | 38 (58) | 36 (58) |
| Body mass index (kg/m2) | 27.1 ± 5.5 | 27.1 ± 6.7 | 27.2 ± 3.9 |
| Previous ablation(s) | 13 (10) | 6 (9) | 7 (11) |
| CHA2DS2-VASc score | 1.9 ± 1.2 | 1.8 ± 1.2 | 2.0 ± 1.2 |
| OSA | 25 (20) | 10 (15) | 15 (24) |
| CPAP/OA | 14 (11) | 4 (6) | 10 (16) |
| Physical therapy | 20 (16) | 11 (17) | 9 (15) |
| AF burden | 5.1% | 5.3% | 5.0% |
| Any anxiety disorder | 31 (24) | 16 (25) | 15 (24) |
| Depressed mood | 37 (29) | 21 (32) | 16 (26) |
| Antiarrhythmics | 32 (25) | 17 (26) | 15 (24) |
| Beta-blockers | 78 (61) | 39 (60) | 39 (63) |
| Beta-blockers “as needed” | 25 (20) | 15 (23) | 10 (16) |
| Anxiolytics “as needed” | 7 (6) | 4 (6) | 3 (5) |
| Sleep medication | 17 (13) | 11 (17) | 6 (10) |
Values are mean ± SD or n (%).
AF-CBT = cognitive behavioral therapy for atrial fibrillation; CHA2DS2-VASc = congestive heart failure, hypertension, age, diabetes mellitus, prior stroke or TIA or thromboembolism, vascular disease, age, and sex category risk score; CPAP = continuous positive airway pressure; OA = oral appliance; OSA = obstructive sleep apnea.